These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33716253)

  • 1. Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response.
    Lin TY; Tsai TH; Chen CT; Yang TW; Chang FL; Lo YN; Chung TS; Cheng MH; Chen WC; Tsai KC; Lee YC
    Exp Anim; 2021 Aug; 70(3):333-343. PubMed ID: 33716253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
    Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
    Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
    Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
    Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of anti-B7-H4-scFv library and screening and identification of anti-B7-H4-scFv].
    Shao L; Xu C; Ji H; Mao W; Wang Y; Liu X; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1260-6. PubMed ID: 27609584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.
    Dangaj D; Scholler N
    Methods Mol Biol; 2015; 1319():37-49. PubMed ID: 26060068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, expression and functional analysis of anti-B7-H4- scFv-CH3 recombinant antibody.
    Ji H; Guo J; Yang Y; Xu C; Mao W
    J Biosci; 2018 Sep; 43(4):661-671. PubMed ID: 30207312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
    Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
    Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
    Leung J; St-Onge P; Stagg J; Suh WK
    Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies.
    Tsai KC; Chiang CW; Lo YN; Chang FL; Lin TY; Chang CY; Chen WC; Lee YC
    Anim Biotechnol; 2019 Oct; 30(4):293-301. PubMed ID: 30261812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of monoclonal antibody against human B7-H4 molecule.
    Zhang N; Fang P; Gu ZJ
    Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):270-4. PubMed ID: 25171007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration.
    Li L; Nian S; Liu Q; Zhang B; Jimu W; Li C; Huang Z; Hu Q; Huang Y; Yuan Q
    Int Immunopharmacol; 2024 May; 132():111926. PubMed ID: 38552297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
    Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
    Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.
    Song X; Zhou Z; Li H; Xue Y; Lu X; Bahar I; Kepp O; Hung MC; Kroemer G; Wan Y
    Cancer Discov; 2020 Dec; 10(12):1872-1893. PubMed ID: 32938586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
    Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
    Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H4 expression in various tumors determined using a novel developed monoclonal antibody.
    Qian Y; Shen L; Cheng L; Wu Z; Yao H
    Clin Exp Med; 2011 Sep; 11(3):163-70. PubMed ID: 21190056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.